| Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group, PW Horby, M Mafham, L Peto, ... Medrxiv, 2021.06. 15.21258542, 2021 | 441* | 2021 |
| Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 397 (10274), 605, 2021 | 317 | 2021 |
| Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trial GE Thwaites, M Scarborough, A Szubert, E Nsutebu, R Tilley, J Greig, ... The Lancet 391 (10121), 668-678, 2018 | 174 | 2018 |
| The 2021 WHO catalogue of Mycobacterium tuberculosis complex mutations associated with drug resistance: a genotypic analysis TM Walker, P Miotto, CU Köser, PW Fowler, J Knaggs, Z Iqbal, M Hunt, ... The Lancet Microbe 3 (4), e265-e273, 2022 | 138 | 2022 |
| Multidrug resistant tuberculosis J Millard, C Ugarte-Gil, DAJ Moore Bmj 350, 2015 | 103 | 2015 |
| Population-level emergence of bedaquiline and clofazimine resistance-associated variants among patients with drug-resistant tuberculosis in southern Africa: a phenotypic and … C Nimmo, J Millard, L van Dorp, K Brien, S Moodley, A Wolf, AD Grant, ... The Lancet Microbe 1 (4), e165-e174, 2020 | 82 | 2020 |
| Bedaquiline resistance in drug-resistant tuberculosis HIV co-infected patients C Nimmo, J Millard, K Brien, S Moodley, L van Dorp, K Lutchminarain, ... European Respiratory Journal 55 (6), 2020 | 69 | 2020 |
| Dynamics of within-host Mycobacterium tuberculosis diversity and heteroresistance during treatment C Nimmo, K Brien, J Millard, AD Grant, N Padayatchi, AS Pym, ... EBioMedicine 55, 2020 | 51 | 2020 |
| A data compendium associating the genomes of 12,289 Mycobacterium tuberculosis isolates with quantitative resistance phenotypes to 13 antibiotics CRyPTIC Consortium PLoS biology 20 (8), e3001721, 2022 | 48 | 2022 |
| Linezolid pharmacokinetics in MDR-TB: a systematic review, meta-analysis and Monte Carlo simulation J Millard, H Pertinez, L Bonnett, EM Hodel, V Dartois, JL Johnson, ... Journal of Antimicrobial Chemotherapy 73 (7), 1755-1762, 2018 | 46 | 2018 |
| Epidemiological cut-off values for a 96-well broth microdilution plate for high-throughput research antibiotic susceptibility testing of M. tuberculosis CRyPTIC Consortium European Respiratory Journal 60 (4), 2022 | 42 | 2022 |
| N-acetyltransferase 2 genotypes amongst Zulu Speaking South Africans and isoniazid/N-acetyl-isoniazid pharmacokinetics during anti-tuberculosis treatment T Mthiyane, J Millard, J Adamson, Y Balakrishna, C Connolly, A Owen, ... Antimicrobial Agents and Chemotherapy, 2020 | 32 | 2020 |
| QT interval prolongation in people treated with bedaquiline for drug-resistant tuberculosis under programmatic conditions: a retrospective cohort study S Isralls, K Baisley, E Ngam, AD Grant, J Millard Open forum infectious diseases 8 (8), ofab413, 2021 | 16 | 2021 |
| Bedaquiline and clofazimine resistance in Mycobacterium tuberculosis: an in-vitro and in-silico data analysis L Sonnenkalb, JJ Carter, A Spitaleri, Z Iqbal, M Hunt, KM Malone, ... The Lancet Microbe 4 (5), e358-e368, 2023 | 13 | 2023 |
| Understanding of research, genetics and genetic research in a rapid ethical assessment in north west Cameroon JA Kengne-Ouafo, JD Millard, TM Nji, WF Tantoh, DN Nyoh, ... International health 8 (3), 197-203, 2016 | 13 | 2016 |
| Assessing the external validity of a randomized controlled trial of anthelminthics in mothers and their children in Entebbe, Uganda JD Millard, L Muhangi, M Sewankambo, J Ndibazza, AM Elliott, EL Webb Trials 15, 1-11, 2014 | 11 | 2014 |
| Mesenchymal hamartoma of the liver: is biopsy always necessary? J Millard, N Fraser, RJ Stewart Pediatric surgery international 22, 622-625, 2006 | 11 | 2006 |
| A crowd of BashTheBug volunteers reproducibly and accurately measure the minimum inhibitory concentrations of 13 antitubercular drugs from photographs of 96-well broth … PW Fowler, C Wright, H Spiers, T Zhu, EML Baeten, SW Hoosdally, ... Elife 11, e75046, 2022 | 10 | 2022 |
| Evolution of Mycobacterium tuberculosis drug resistance in the genomic era C Nimmo, J Millard, V Faulkner, J Monteserin, H Pugh, EO Johnson Frontiers in Cellular and Infection Microbiology 12, 954074, 2022 | 9 | 2022 |
| A data compendium of Mycobacterium tuberculosis antibiotic resistance A Brankin, KM Malone, I Barilar, S Battaglia, E Borroni, AP Brandao, ... bioRxiv, 2021.09. 14.460274, 2021 | 7 | 2021 |
